Key facts
- This page summarizes Ross Douglas T.'s Form 4 filing for Oncocyte Corp (OCX).
- 5 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 20 Dec 2022, 15:05.
Ross Douglas T. - 16 Dec 2022 Form 4 Insider Report for Oncocyte Corp (OCX)
- Reporting relationship
- Former CSO.
- Issuer ticker
- OCX
- Reported as of
- 16 Dec 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Dec 2022, 15:05:38 UTC
- Prior SEC filing
- 17 Aug 2022
- Next SEC filing
- 22 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Douglas Ross
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ross Douglas T. filed Form 4 for Oncocyte Corp (OCX) on 20 Dec 2022.
Change
- Previous filing in this sequence was filed on 17 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCX
transaction
Common Stock, no par value
Disposed to Issuer
- Transaction value
- $0
- Shares
- -150,000
- Change %
- -88%
- Price
- $0.000000
- Shares after
- 20,317
- Date
- 01 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OCX
transaction
Derivative
Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- $0
- Shares
- -83,334
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 166,666
- Date
- 16 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 83,334
- Exercise price
- $1.93
- Footnotes
- F2
OCX
transaction
Derivative
Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- $0
- Shares
- -143,438
- Change %
- -56%
- Price
- $0.000000
- Shares after
- 111,562
- Date
- 16 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 143,438
- Exercise price
- $5.34
- Footnotes
- F2
OCX
transaction
Derivative
Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- $0
- Shares
- -100,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 16 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $1.15
- Footnotes
- F2
OCX
transaction
Derivative
Option to Purchase Common Stock
Disposed to Issuer
- Transaction value
- $0
- Shares
- -100,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 16 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $1.15
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining restricted stock units immediately vested on December 16, 2022.
Footnote F2
The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022.